|
 |
|
| Regarding R&D, in Ethical Pharmaceuticals we concentrate our management resources on gastrointestinal therapies. In Consumer Healthcare, we strive to develop original products suitable for self-medication. |
|
|
|
|
|
|
|
| Zeria has achieved independent growth as a Specialty Pharma by concentrating functions ranging from research and development to sales and marketing on the field of gastrointestinal therapies and allocating management resources to this field while creating our own original new pharmaceuticals. We are also actively involved in joint R&D and marketing partnerships with companies both in Japan and overseas. |
|
|
|
|
|
|
|
| Since our founding, we have anticipated the needs of the times based on the concepts of Self-Prevention and Self-Cure and have offered original, high-quality, over-the-counter (OTC) drugs in an effort to contribute to self-medication. Among these, our flagship Chondroitin product range that includes Chondroitin ZS Tablets maintains a dominant market share as the top brand in the field. |
|
|
|
|
|
|
|
| Our activities in production and distribution are engaged in constantly pursuing product quality and delivering "peace of mind" and "safety" to consumers. |
|
|
|
|
|